Literature DB >> 31256572

Health Financing Consequences of Implementing Health Transformation Plan in Iran: Achievements and Challenges.

Leila Doshmangir1,2,3, Mohammad Bazyar4, Behzad Najafi5,6, Hassan Haghparast-Bidgoli7.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31256572      PMCID: PMC6600021          DOI: 10.15171/ijhpm.2019.18

Source DB:  PubMed          Journal:  Int J Health Policy Manag        ISSN: 2322-5939


× No keyword cloud information.

Dear Editor,

Backing by strong political support of the government, Ministry of Health and Medical Education (MoHME) launched a major and ambitious reform in Iran on May 5, 2014 entitled “Health Transformation Plan (HTP)” to address the main challenges in the healthcare system including high levels of out-of-pocket (OOP) payments, irrational medical tariffs, and low quality healthcare services.[1,2] HTP aimed to address these issues through a number of strategies. These included increasing government spending on health, extending health insurance coverage, increasing medical tariffs, creating new hospitals in deprived regions and increasing hospital beds and recruiting more physicians and health workers, such as nurses and midwifes, in remote areas as well as repairing and renovating public hospitals and health facilities.[3,4] HTP intended to cover four domains including medical services, public health and primary healthcare, medical education, and pharmaceutical products. Aiming to implement HTP, the government injected more than 85 000 billion Iranian Rials (US$3196 million or INT$ 10 316 million [) additional funds into the healthcare system. The additional funds were generated by allocating 10% of targeted subsidies and 1% of value-added tax to the healthcare system and by increasing (though not considerable) the share of healthcare budget from governmental budget. In November 2014, as the third step of HTP, medical tariffs increased on average by 120% in order to tackle informal payments and making medical tariffs more realistic. As a result, the total health expenditure rose by 39% and its share as % of gross domestic product rose from 6.1% in 2013 to 8.13% in 2016 (Table). As shown in the Table, the shares of all financing sources have increased. For instance, OOP net amount has grown from 9.9% in 2013 to 18% in 2015 and has decreased to 2.2% in 2016. In contrast increase in the share of governmental health expenditures as percent of total governmental budget resulted in substantial reduction of OOP as % of total health expenditure, which peaked in the first year of HTP implementation with 9% reduction and with a slight decline afterward (Figure). Although the proportion of OOP has decreased, available evidence shows mixed results regarding the reduction in the incidence of catastrophic health expenditure.[5-8] However, more rigorous research needed to explore the impact of HTP in this area.
Table

The Changes in Healthcare Expenditure During 2013-2016

2013 2014 2015 2016
THE (in billion IRR)621 623864 6041 036 8461 146 138
THE % of GDP6.17.58.78.13
THE annual growth (%)-392010
Annual growth (%)
Governmenta 58.885.8912.4
SHI41.769.939.220.9
OOP9.914.7182.2
Others51.313.410.59.2
GHE % of government budgetb 11.416.22119

Abbreviations: IRR, Iranian Rials; THE, total health expenditure; GDP, gross domestic product; SHI, social health insurance; OOP, out-of-pocket; GHE, governmental health expenditure.

a Government including Local, state and central Government based on National Health Accounts classification.

b It is not equal to general government health expenditure (GGHE) % of general government expenditure (GGE).

Source: National Health Accounts, MoHME.

Figure
Abbreviations: IRR, Iranian Rials; THE, total health expenditure; GDP, gross domestic product; SHI, social health insurance; OOP, out-of-pocket; GHE, governmental health expenditure. a Government including Local, state and central Government based on National Health Accounts classification. b It is not equal to general government health expenditure (GGHE) % of general government expenditure (GGE). Source: National Health Accounts, MoHME. Changes in the Share of Different Sources of Total Health Expenditure as a Result of HTP. Abbreviations: HTP, Health Transformation Plan; OOP, out-of-pocket; Prvt HI: private health insurances. Source: National Health Accounts, MoHME. By allocating 5500 billion Iranian Rials (2014 US$207 million and INT$ 668 million) to the Iran Health Insurance Organization (IHIO) by the government, free health insurance coverage was provided for uninsured individuals, who were mainly self-employed individuals living in urban areas. In 2014 nearly 11 million people were covered by IHIO and overall population coverage raised from 83% to 92%. The increase in insurance coverage, expanding the health insurance benefit package, and reduction in OOP, enhanced access to and utilization of the healthcare services, and in turn, led to satisfaction among the public.[8,9] For instance, in 2015 and for patients covered by IHIO alone, utilization of inpatient services and average hospitalization costs increased by 6% and by more than 73% respectively.[10] The rapid increase in the provision and utilization of healthcare services might be driven partly by unmet needs before the implementation of the HTP and partly because of consumer moral hazard, due to reduction in co-insurance rates in public hospitals, and providers’ induced demand, caused by increasing medial tariffs and open-ended fee-for-service payments. Rising expenditures put high financial pressure on the government and public health insurance funds, including IHIO and social security organization, which led to long (up to one year) delays in reimbursing the hospitals and medical centers across the country. This situation put the government in a horrendous bind and made the MoHME to appeal to severe spending-cuts policies. For instance, MoHME forced medical universities to cut down their spending at least by 20% in 2018 compared to 2017.[10] Alongside or even before the implementation of HTP, some other reforms to improve efficiency of healthcare system were required. These reforms included establishing evidence-informed demand and supply-side policies such as extending the referral system and family physician programme to urban areas and population segments other than rural residents, moving forwards to prospective provider payment mechanisms (such as capitation, diagnosis related groups, and pay for performance), applying clinical guidelines, as well as revising the benefit packages by including the most cost-effective interventions. Moreover, organizational reforms in public hospitals aim to balance between revenues and expenses is a prerequisite[11-13] and HTP should try to affect structure and process of healthcare provision as well as culture and values of healthcare organizations to avoid over use and provider’s induced demand. HTP could have been used as a golden opportunity to implement the structural reforms, some mentioned above, which has been emphasized in the national development plans over the last decades. The speed of policy reform process should also be taken into account. The new government began officially on August 3, 2013 and in less than one year, on May 5, 2014, the HTP as a major reform began, though with more focus on financing dimension of the healthcare system. It would have been better for the MoHME to take a more conservative approach and implement the HTP gradually or in some provinces as a pilot program first, explore potential impacts and identify its implementation pitfalls, and then scale it up at the national level after making necessary amendments in the plan. In launching a large-scale health reform such as HTP, if necessary considerations for long-term financial sustainability are not taken into account, the short-time achievements would not last long, and in long run, it can have negative impacts on the performance of healthcare system as a whole. However, with all its pitfalls and limitations, HTP is a window of opportunity to pave the way towards universal health coverage and the policy-makers should try to strengthen the plan, using the strategies mentioned above, and do not let this opportunity pass.

Ethical issues

Not applicable.

Competing interests

Authors declare that they have no competing interests.

Authors’ contributions

LD and MB contributed to the conception of the work. LD drafted the letter. MB, BN, and HHB provided critical comments on the draft. All authors approved the final version.

Authors’ affiliations

1Tabriz Health Services Management Research Center, Iranian Center of Excellence in Health Management, Tabriz University of Medical Sciences, Tabriz, Iran. 2Social Determinants of Health Research Center, Health Management and Safety Promotion Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran. 3Department of Health Services Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran. 4Department of Public Health, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran. 5Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 6Department of Health Economics, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran. 7Institute for Global Heath, University College London, London, UK. [1] One dollar in US and International exchange rate (purchasing power parity) was equal to 26 594 and 8239 Iranian Rial in 2014, respectively (Source: International Monitory Fund, 2016).
  12 in total

1.  Health Sector Evolution Plan in Iran; Equity and Sustainability Concerns.

Authors:  Maziar Moradi-Lakeh; Abbas Vosoogh-Moghaddam
Journal:  Int J Health Policy Manag       Date:  2015-08-31

2.  Iran's health-care system in transition.

Authors:  Bahram Heshmati; Hassan Joulaei
Journal:  Lancet       Date:  2016-01-02       Impact factor: 79.321

3.  Opening the Black Box: The Experiences and Lessons From the Public Hospitals Autonomy Policy in Iran.

Authors:  Leila Doshmangir; Arash Rashidian; Mehdi Jafari; Amirhossein Takian; Hamid Ravaghi
Journal:  Arch Iran Med       Date:  2015-07       Impact factor: 1.354

4.  The experience of implementing the board of trustees' policy in teaching hospitals in Iran: an example of health system decentralization.

Authors:  Leila Doshmangir; Arash Rashidian; Hamid Ravaghi; Amirhossein Takian; Mehdi Jafari
Journal:  Int J Health Policy Manag       Date:  2014-10-31

5.  Catastrophic Health Expenditure After the Implementation of Health Sector Evolution Plan: A Case Study in the West of Iran.

Authors:  Bakhtiar Piroozi; Ghobad Moradi; Bijan Nouri; Amjad Mohamadi Bolbanabad; Hossein Safari
Journal:  Int J Health Policy Manag       Date:  2016-07-01

6.  Out-of-Pocket and Informal Payment Before and After the Health Transformation Plan in Iran: Evidence from Hospitals Located in Kurdistan, Iran.

Authors:  Bakhtiar Piroozi; Arash Rashidian; Ghobad Moradi; Amirhossein Takian; Hooman Ghasri; Tayyeb Ghadimi
Journal:  Int J Health Policy Manag       Date:  2017-10-01

7.  Recent Iranian Health System Reform: An Operational Perspective to Improve Health Services Quality.

Authors:  Mahdi Mahdavi; Mahboubeh Parsaeian; Ebrahim Jaafaripooyan; Shahram Ghaffari
Journal:  Int J Health Policy Manag       Date:  2018-01-01

8.  Inpatient Out-of-Pocket in Iran After Health Transformation Plan.

Authors:  Sulmaz Ghahramani; Kamran Bagheri Lankarani
Journal:  Int J Health Policy Manag       Date:  2018-09-01

9.  Iran towards universal health coverage: The role of human resources for health.

Authors:  Elham Ehsani-Chimeh; Haniye Sadat Sajadi; Reza Majdzadeh
Journal:  Med J Islam Repub Iran       Date:  2018-10-16

10.  Assessment of the Efficiency of Hospitals Before and After the Implementation of Health Sector Evolution Plan in Iran Based on Pabon Lasso Model.

Authors:  Ghobad Moradi; Bakhtiar Piroozi; Hossein Safari; Nader Esmail Nasab; Amjad Mohamadi Bolbanabad; Arezoo Yari
Journal:  Iran J Public Health       Date:  2017-03       Impact factor: 1.429

View more
  13 in total

1.  Future Development Through the Past: Pathology of the Financing Dimension of Iran's Health Transformation Plan.

Authors:  Leila Doshmangir; Behzad Najafi; Hakimeh Mostafavi; Esmaeil Moshiri
Journal:  Clinicoecon Outcomes Res       Date:  2020-07-07

2.  Change in health spending after implementation of a health transformation plan in Iran: an interrupted time series analysis.

Authors:  Reza Esmaeili; Samad Rouhani; Jamshid Yazdani Charati; Masoud Khandehroo
Journal:  Cost Eff Resour Alloc       Date:  2021-06-03

3.  Setting health care services tariffs in Iran: half a century quest for a window of opportunity.

Authors:  Leila Doshmangir; Arash Rashidian; Farhad Kouhi; Vladimir Sergeevich Gordeev
Journal:  Int J Equity Health       Date:  2020-07-06

4.  Assessing the efficiency of Iran health system in making progress towards universal health coverage: a comparative panel data analysis.

Authors:  Haniye Sadat Sajadi; Zahra Goodarzi; Amirhossein Takian; Efat Mohamadi; Alireza Olyaeemanesh; Farhad Hosseinzadeh Lotfi; Hamid Sharafi; Somayeh Noori Hekmat; Matthew Jowett; Reza Majdzadeh
Journal:  Cost Eff Resour Alloc       Date:  2020-06-29

5.  Financing of physical rehabilitation services in Iran: a stakeholder and social network analysis.

Authors:  Saeed Shahabi; Ahmad Ahmadi Teymourlouy; Hosein Shabaninejad; Mohammad Kamali; Kamran Bagheri Lankarani
Journal:  BMC Health Serv Res       Date:  2020-07-01       Impact factor: 2.655

Review 6.  Iran health insurance system in transition: equity concerns and steps to achieve universal health coverage.

Authors:  Leila Doshmangir; Mohammad Bazyar; Arash Rashidian; Vladimir Sergeevich Gordeev
Journal:  Int J Equity Health       Date:  2021-01-14

7.  The impacts of family physician plan and health transformation plan on hospitalization rates in Iran: an interrupted time series.

Authors:  Samad Rouhani; Reza Esmaeili; Jamshid Yazdani Charati; Masoud Khandehroo
Journal:  BMC Health Serv Res       Date:  2021-07-05       Impact factor: 2.655

8.  Ensuring adequate health financing to prevent and control the COVID-19 in Iran.

Authors:  Masoud Behzadifar; Mahboubeh Khaton Ghanbari; Ahad Bakhtiari; Meysam Behzadifar; Nicola Luigi Bragazzi
Journal:  Int J Equity Health       Date:  2020-05-06

9.  Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.

Authors:  Alireza Olyaaeemanesh; Ebrahim Jaafaripooyan; Akbar Abdollahiasl; Majid Davari; Seyyed Meysam Mousavi; Mansoor Delpasand
Journal:  Health Res Policy Syst       Date:  2021-12-23

Review 10.  Financial Protection Indexes and the Iranian Health Transformation Plan: A Systematic Review.

Authors:  Banafshe Darvishi; Masoud Behzadifar; Mahboubeh Khaton Ghanbari; Seyed Jafar Ehsanzadeh; Ahad Bakhtiari; Meysam Behzadifar; Samad Azari; Nicola Luigi Bragazzi
Journal:  Yale J Biol Med       Date:  2021-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.